• Home
  • Information for patients
    • Diseases
      • Intestinal diseases
      • Diabetic foot syndrome
      • Skin diseases
      • Infectious diseases
      • Cancer
      • Concomitant and secondary diseases
      • Rheumatic diseases
      • Urological diseases
    • Pharmacovigilance / Report about an Adverse Drug Reaction
    • Contact
  • Healthcare professionals
    • Therapeutics
    • Diagnostics
      • News
      • Events
      • Contact us
    • Products
    • Safety data sheets / Summary of Product Characteristics (SPC)
    • Pharmacovigilance / Report about an Adverse Drug Reaction
    • Contact
  • Career
  • medac
    • About medac
    • Corporate Video
    • Corporate Philosophy
    • History
    • medac Environmental management
    • Business Development
    • Therapeutics
    • Research and Development
    • Subsidiaries and holdings
    • Logistics
    • medac as Sponsor
  • Contact
    • Your way to medac
    • Logistic Centre
    • Affiliates and representative Offices
    • Subsidaries and Holdings
NewsEventsmedac Germany
  • medac International »
  • Information for patients »
  • Diseases »
  • Intestinal diseases

Information for patients

  • Diseases
    • Intestinal diseases
    • Diabetic foot syndrome
    • Skin diseases
    • Infectious diseases
    • Cancer
    • Concomitant and secondary diseases
    • Rheumatic diseases
    • Urological diseases
  • Pharmacovigilance / Report about an Adverse Drug Reaction
  • Contact

Intestinal diseases

Information for patients with intestinal diseases:

Intestinal diseases
  • Bowel cancer
  • Chronic inflammatory bowel disease
  • Pancreatic cancer – cancer of the pancreas
  • Stomach cancer - gastric carcinoma

Contact

medac GmbH
Theaterstrasse 6
22880 Wedel / Germany

Head office

phone: +(49)4103-8006-0
fax: +(49)4103-8006-100
mail: contact(at)medac.de

Contact form

medac GmbH, Theaterstrasse 6, 22880 Wedel / Germany
Head Office, phone: +49 (0)4103 8006-0, fax: +49 (0)4103 8006-100,

mail: contact(at)medac.de

  • Contact
  • Legal Notice
  • Privacy
  • Standard Terms and Conditions